Post-acute effectiveness of lithium in pediatric bipolar i disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 2, 2013, Pages 80-90

  Findling, Robert L ^a   Kafantaris, Vivian ^b   Pavuluri, Mani ^c   McNamara, Nora K ^d   Frazier, Jean A ^e   Sikich, Linmarie ^f   Kowatch, Robert ^g   Rowles, Brieana M ^d   Clemons, Traci E ^h   Taylor Zapata, Perdita ⁱ  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g NATIONWIDE CHILDREN S HOSPITAL   (United States)

^h EMMES CORPORATION   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ARIPIPRAZOLE; LITHIUM; METHYLPHENIDATE; QUETIAPINE; RISPERIDONE; THYROTROPIN; VALPROIC ACID;

ABDOMINAL PAIN; ADOLESCENT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR I DISORDER; BODY MASS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; MANIA; MENTAL PATIENT; NEUTROPHIL COUNT; OUTPATIENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRESCRIPTION; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REMISSION; SCHOOL CHILD; SIDE EFFECT; SUICIDE; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TREMOR; VOMITING; WEIGHT GAIN; YOUNG MANIA RATING SCALE;

ADOLESCENT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875431653     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0063     Document Type: Article

References (49)

1. Aman M, Leone S, Lecavalier L, Park L, Buican B, Coury D: The Nisonger Child Behavior Rating Form: Typical IQ version. Int Clin Psychopharmacol 23:232-242, 2008.
2. Barbesino G: Drugs affecting thyroid function. Thyroid 20:763-770, 2010.
3. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ: A randomized, placebo-controlled trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57:481-489, 2000.
4. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J, Lamictal 606 Study Group: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patientswith bipolar I disorder. Arch Gen Psychiatry 60:392-400, 2003.
5. Brannan AM, Heflinger CA, Bickman L: The caregiver strain questionnaire: measuring the impact of the family of living with a child with serious emotional disturbance. J Emot Behav Disord 5:212-222, 1997.
6. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J, Lamictal 605 Study Group: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64:1013-1024, 2003.
7. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM: A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41:1216-1223, 2002.
8. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. New York: The Guilford Press; 1998.
9. Findling RL, Frazier JA, Kafantaris V, Kowatch R, McClellan J, Pavuluri M, Sikich L, Hlastala S, Hooper SR, Demeter CA, Bedoya D, Brownstein B, Taylor-Zapata P: The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. Child Adolesc Psychiatry Ment Health 21, 2008.
10. Findling RL, Gracious BL, McNamara NK, Youngstrom EA, Demeter CA, Branicky LA, Calabrese JR: Rapid, continuous cycling and psychiatric comorbidity in pediatric bipolar I disorder. Bipolar Disord 3:202-210, 2001.
11. Findling RL, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA, Sikich L, Kowatch R, Lingler J, Faber J, Rowles BM, Clemons TE, Taylor-Zapata P: Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 21:195-205, 2011.
12. Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE, Calabrese JR: Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42:895-901, 2003.
13. Findling RL, Nylias M, Forbes RA, McQuade RD, Jin N, Iwamoto T, Ivanova S, Carson WH, Chang KD: Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: A randomized, double-blind, placebo-controlled study. J Clin Psychiatry 70:1445-1451, 2009.
14. Findling RL, Pavuluri MN: Lithium. In: Treatment of Bipolar Disorder in Children and Adolescents. Edited by Geller B, DelBello M. New York: Guilford Press; 2008, pp. 43-68.
15. Findling RL, Short EJ, McNamara NK, Demeter CA, Stansbrey RJ, Gracious BL, Whipkey R, Manos MJ, Calabrese JR: Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:1445-1453, 2007.
16. Geller B, Luby JL, Joshi P, Wagner KD, Emslie GJ, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P: A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry 69:515-528, 2012.
17. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, Del-Bello MP, Soutullo CA: Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157-164, 2000.
18. Gracious BL, Findling RL, Seman C, Youngstrom EA, Demeter CA, Calabrese JR: Elevated thyrotropin in bipolar youths prescribedboth lithium and divalproex sodium. J Am Acad Child Adolesc Psychiatry 43:215-220, 2004.
19. Greenhill LL, Vitiello B, Fisher P, Levine J, Davies M, Abikoff H, Chrisman AK, Chuang S, Findling RL, March J, Scahill L, Walkup J, Riddle MA: Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Adolesc Psychiatry 43:1488-1496, 2004.
20. Haas M, DelBello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumaker V: Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Bipolar Disord 11:687-700, 2009.
21. Hughes CW, Rintelmann J, Emslie GJ, Lopez M, MacCabe N: A revised anchored version of the BPRS-C for childhood psychiatric disorders. J Child Adolesc Psychopharmacol 11:77-93. 2001.
22. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59:530-537, 2002.
23. Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM: Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. J Am Acad Child Adolesc Psychiatry 40:1448-1456, 2001.
24. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
25. Klein RG, Abikoff H, Barkley RA, Campbell M, Leckman JF, Ryan ND, Solanto MV, Whalen CK: Clinical trials in children and adolescents. In: Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. Edited by Prien RF, Robinson DS. New York: Raven Press, Ltd.; 1994, pp. 501-546.
26. Lepkifker E, Sverdlik A, Iancu I, Ziv R, Segev S, Kotler M: Renal insufficiency in long-term lithium treatment. J Clin Psychiatry 65:850-856, 2004.
27. Lingjaerde 0, Ahlfors UG, Bech P, Dencker SJ, Elgen K: The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 334:1-100, 1987.
28. Manzano J, Salvador A: Antecedents of severe affective (mood) disorders: patients examined as children or adolescents and as adults. Acta Paedopsychiatr 56:11-18, 1993.
29. McCann SM, Daly J, Kelly CB: The impact of long-term lithium treatment on renal function in an outpatient population. Ulster Med J 77:102-105, 2008.
30. Muzina DJ, Calabrese JR: Maintenance therapies in bipolar disorder: Focus on randomized controlled trials. Aust N Z J Psychiatry 39:652-661, 2005.
31. National Institute of Mental Health: Clinical Global Impressions Scale. Psychopharmacol Bull 21:839-843, 1985a.
32. Pavuluri MN, Henry DB, Carbray JA, Sampson GA, Naylor MW, Janicak PG: A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. J Child Adolesc Psychopharmacol 16:336-350, 2006.
33. Pavuluri MN, Henry DB, Carbray JA, Sampson G, Naylor MW, Janicak PG: Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 82(Suppl 1):S103-111, 2004.
34. Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, Sachs GS, Nierenberg AA: Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 55:875-881, 2004.
35. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME: Predictors of recurrence in bipolar disorder: preliminary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 163:217-224, 2006.
36. Poznanski EO, Miller E, Salguero C, Kelsh RC: Preliminary studies of the reliability and validity of the Children's Depression Rating Scale. J Am Acad Child Psychiatry 23:191-197, 1984.
37. Research Units on Pediatric Psychopharmacology Anxiety Study Group: The Pediatric Anxiety Rating Scale (PARS): Development and psychometric properties. J Am Acad Child Adolesc Psychiatry 41:1061-1069, 2002.
38. Scheffer RE, Kowatch RA, Carmody T, Rush AJ: Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 162:58-62, 2005.
39. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 40:1228-1231, 1983.
40. Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:1-19, 1970.
41. Snaith RP, Constantopoulos AA, Jardine MY, McGuffin P: A clinical scale for the self-assessment of irritability. Br J Psychiatry 132:164-171, 1978.
42. Tillman R, Geller B, Bolhofner K, Craney JL, Williams M, Zimerman B: Ages of onset and rates of syndromal and subsyndromal comorbid DSMIV diagnoses in a prepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry 42:1486-1493, 2003.
43. Tohen M, Kryzhanovskaya L, Carlson G, DelBello M, Wozniak J, Kowatch R, Wagner K, Findling RL, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J: Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 164:1547-1556, 2007.
44. Tredget J, Kirov A, Kirov G: Effects of chronic lithium treatment on renal function. J Affect Disord 126:436-440, 2010.
45. Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M: A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 48:519-532, 2009.
46. Yatham LN, Kauer-Sant'Anna M, Bond DJ, Lam RW, Torres I: Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania project. Can J Psychiatry 54:105-112, 2009.
47. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133:429-435, 1978.
48. Youngstrom EA, Frazier TW, Demeter C, Calabrese JR, Findling RL: Developing a 10-item scale fromthe Parent General Behavior Inventory for children and adolescents. J Clin Psychiatry 69:831-839, 2008.
49. Zhang ZJ, Li Q, Kang WH, Tan QR, Gao CG, Zhang FG, Wang HH, Ma XC, Chen C, Wang W, Guo L, Zhang YH, Yang XB, Zhang RG: Differences in hypothyroidism between lithium-free and-treated patients with bipolar disorders. Life Sci 78:771-776, 2006.